SHENZHEN, China, March 16, 2026 (GLOBE NEWSWIRE)-- ZJK Industrial Co., Ltd. (NASDAQ: ZJK) ("ZJK Industrial”, "ZJK” or the "Company”), a high-tech enterprise specializing in the manufacturing and sale ...
David and Matt discuss the meaning of James Talarico's decisive victory in Texas democratic senate primary and how Talarico leaned into class warfare rhetoric. You can get four print issues of Jacobin ...
SHENZHEN, China, Feb. 11, 2026 /PRNewswire/ -- Big Tree Cloud Holdings Limited (the "Company") (NASDAQ: DSY) today announced that it held an extraordinary general meeting on January 30, 2026, at which ...
The San Francisco Bay Area is home to at least one-third of the value of the entire U.S. stock market. Late last year, you couldn’t escape a chilling billboard campaign, meant to be cheeky, from an ...
Around 30 schools from Bengal are expected to be part of the cohort of 250 schools selected from across the country, CISCE chief executive and secretary Joseph Emmanuel told Metro Joseph Emmanuel, ...
Columbia piloted a program to “de-densify” its class schedule for the spring 2026 semester by implementing a 40 percent distributional cap on courses scheduled to start between 10 a.m. and 2 p.m., ...
Mercedes-Benz has partially revealed its next-generation S-Class in the UAE, serving as a robotaxi prototype. These driverless taxis are intended to act as a rolling laboratory for Mercedes-Benz’s ...
Education advocates made a last-ditch effort Thursday to persuade New York City officials to request a delay of the state’s class-size law before Mayor-elect Zohran Mamdani takes office. The 2022 law ...
Belenos Biosciences Inc., a private, clinical-stage biotechnology company today announced that its China partner Keymed Biosciences has reported topline results from a Phase 1b study (n=46) of BEL512 ...
ABSTRACT: In order to implement the spirit of the construction of first-class undergraduate courses by the Ministry of Education and promote the innovation of teaching models for foreign-language ...
The fibroblast growth factor receptor 2b (FGFR2b) inhibitor bemarituzumab (Amgen) significantly improved overall survival (OS) compared with a placebo for some gastric cancers. In the phase III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results